Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 1
1961 1
1985 1
1986 3
1987 1
1989 2
1990 1
1991 2
1993 4
1994 3
1995 2
1996 1
1997 2
1998 1
1999 3
2000 4
2001 12
2002 23
2003 25
2004 22
2005 20
2006 35
2007 25
2008 20
2009 14
2010 13
2011 20
2012 12
2013 15
2014 11
2015 14
2016 13
2017 9
2018 5
2019 2
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 17409317

320 results
Results by year
Filters applied: . Clear all
Page 1
Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
Eijkelkamp WB, Zhang Z, Remuzzi G, Parving HH, Cooper ME, Keane WF, Shahinfar S, Gleim GW, Weir MR, Brenner BM, de Zeeuw D. Eijkelkamp WB, et al. J Am Soc Nephrol. 2007 May;18(5):1540-6. doi: 10.1681/ASN.2006050445. Epub 2007 Apr 4. J Am Soc Nephrol. 2007. PMID: 17409317 Free article. Clinical Trial.
Renoprotective effect of the addition of losartan to ongoing treatment with an angiotensin converting enzyme inhibitor in type-2 diabetic patients with nephropathy.
Abe H, Minatoguchi S, Ohashi H, Murata I, Minagawa T, Okuma T, Yokoyama H, Takatsu H, Takaya T, Nagano T, Osumi Y, Kakami M, Tsukamoto T, Tanaka T, Hiei K, Fujiwara H. Abe H, et al. Hypertens Res. 2007 Oct;30(10):929-35. doi: 10.1291/hypres.30.929. Hypertens Res. 2007. PMID: 18049024 Clinical Trial.
320 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page